HGS drug flop latest genomics setback

نویسندگان

چکیده

منابع مشابه

Drug-resistant tuberculosis: latest advances.

At the start of 2012, a report from Mumbai, India, that described patients with strains of tuberculosis deemed resistant to all antituberculosis drugs set in motion an eventful year for this disease. What was referred to as totally drug-resistant tuberculosis attracted intense media attention and much debate among health professionals worldwide. Experts convened in March, 2012, by WHO to discus...

متن کامل

Genomics and drug response.

From the Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School, Mayo Clinic, Rochester, MN (L.W., R.M.W.); and the UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill (H.L.M). Address reprint requests to Dr. Weinshilboum at the Division of Clinical Pharmacology, Department o...

متن کامل

Structural genomics and drug discovery

Structure determination has already proven useful for lead optimization and direct drug design. The number of high-resolution structures available in public databases today exceeds 30,000 and will definitely aid in structure-based drug design. Structural genomics approaches covering whole genomes, topologically similar proteins or gene families are great assets for further progress in the devel...

متن کامل

Antiepileptic drug pregnancy registries: do the latest findings concur?

Registry versus clinical trial The main goal of pregnancy registries includes the rapid identification of signals of increased teratogenic risk as quickly as possible, which is especially important for newly available anti epileptic drugs (AEDs) [1–3]. When the association between an increased risk and an AED is found in a registry, the cause can be further explored in a case–control study or a...

متن کامل

Latest on the pathology of drug-eluting stents

The introduction of drug-eluting stents (DES) has significantly reduced restenosis when compared with bare-metal stents and are considered the standard of care in the treatment of symptomatic coronary artery disease. However, late stent thrombosis (LST), potentially resulting in a fatal occlusion of the vessel, emerged as a major concern in first-generation DES (polymer-based sirolimusand pacli...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nature Biotechnology

سال: 2002

ISSN: 1087-0156,1546-1696

DOI: 10.1038/nbt0602-533a